Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

SHPS-1/SIRP-1 α polyclonal antibody

 
ADI-KAP-TK140-E 100 µg 356.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Host:Rabbit
 
Immunogen:Synthetic peptide corresponding to the sequence near the C-terminus of human SHPS-1/SIRP-1α.
 
UniProt ID:P78324
 
GenBank ID:D86043
 
Species reactivity:Human, Mouse, Rat
 
Applications:ICC, WB
 
Recommended Dilutions/Conditions:Immunocytochemistry (1µg/ml)
Western Blot (0.5-1.0µg/ml, colorimetric)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Application Notes:Detects a band of ~80-95kDa by Western blot.
 
Purity Detail:DEAE purified.
 
Formulation:Liquid. In PBS containing 0.02% sodium azide.
 
Shipping:Blue Ice Not Frozen
 
Long Term Storage:+4°C
 
Scientific Background:SHPS-1 is a member of the gene family called the signal regulatory proteins of which there are at least fifteen members. SHPS-1 is a substrate of many activated tyrosine kinases such as Insulin receptor and EGFR, amongst others. SHPS-1 has regulatory effects on cellular responses induced by serum, growth factors, insulin, oncogenes, growth hormones and cell adhesion and plays a general role in different physiological and pathological processes.
 
KAP-TK140 WB
Western blot analysis of SIRP alpha in THP-1 whole cell lysate with SIRP alpha antibody at 1:2000 dilution.
KAP-TK140 ICC
Immunocytochemistry analysis of SIRP alpha in THP-1 cells with SIRP alpha antibody at 1µg/ml.
Please mouse over
KAP-TK140 WB KAP-TK140 ICC

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
SHPS-1
By biological activity:
SHPS-1 Polyclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,